HomeIDXG • OTCMKTS
add
Interpace Biosciences Inc
Previous close
$1.47
Day range
$1.55 - $1.55
Year range
$0.62 - $3.54
Market cap
6.78M USD
Avg Volume
4.77K
P/E ratio
6.09
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 10.28M | 23.42% |
Operating expense | 4.82M | -1.09% |
Net income | 890.00K | 156.91% |
Net profit margin | 8.65 | 146.08% |
Earnings per share | — | — |
EBITDA | 1.39M | 180.65% |
Effective tax rate | 0.61% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 3.50M | -27.55% |
Total assets | 13.02M | -18.51% |
Total liabilities | 28.16M | -13.40% |
Total equity | -15.14M | — |
Shares outstanding | 4.38M | — |
Price to book | -0.10 | — |
Return on assets | 24.20% | — |
Return on capital | -100.72% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 890.00K | 156.91% |
Cash from operations | 1.14M | 513.04% |
Cash from investing | -142.00K | 87.08% |
Cash from financing | -2.53M | -2,288.68% |
Net change in cash | -1.53M | -3.58% |
Free cash flow | 981.75K | 677.92% |
About
Founded
1986
Headquarters
Website
Employees
108